Antibiotic resistance and the quest for discovery – Professor Mathew Upton

About us

The University of Plymouth is proud to present the Inaugural Professorial Lecture of Professor Mathew Upton.

Antibiotics have saved countless lives since their discovery in 1928, and are essential to safely carry out routine medical procedures like joint replacements, transplants, heart surgery and cancer therapy. As strains of microbes emerge that are resistant to the effects of antibiotics, our entire medical system could be undermined, as many procedures become too risky to carry out.

Professor of Medical Microbiology, Mathew Upton, is a rising star in the field of antimicrobial resistance, dedicating his work to discovering potential sources for antimicrobials that can be turned into the new classes of antibiotic; there have been no new classes of antibiotic introduced into clinical use in the last 30 years.

In this insightful lecture Mathew reflects on his extensive research in the field of microbiology, from his first spark of interest in studying antimicrobial resistance, to creating the Antibiotic Resistant Pathogens Research Group, to the launch of his spinout company Amprologix.

Amprologix is the culmination of uniting his expertise with industrial partner Ingenza Ltd, to convert his antimicrobial discoveries into new antibiotics that could one day be distributed globally. With a potential new antibiotic already on the horizon for Amprologix, this lecture presents a unique opportunity to hear the latest research in this frontier of medical science.

You are welcome to join us for University of Plymouth's Inaugural Professorial Lecture series, which provide a milestone event in a professorial career. Through these we can promote and celebrate the academic reputation and achievements within their research.